Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. 1990

B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104-4268.

We have mapped a linear epitope recognized by the virus-neutralizing monoclonal antibody 6-15C4 within the primary sequence of the G protein from the Evelyn-Rokitnicki-Abelseth strain of rabies virus. This was accomplished by using fragments of the rabies virus G protein and deduced amino acid sequences of neutralization-resistant variant rabies viruses. The monoclonal antibody 6-15C4 specifically recognized a synthetic peptide (peptide G5-24) which resembles the 6-15C4 epitope in structure. In addition, a tandem peptide constructed from the G5-24 peptide and a dominant TH cell epitope of the rabies virus N protein induced protective immunity against lethal rabies virus challenge infection in mice.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006377 T-Lymphocytes, Helper-Inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Helper Cell,Helper Cells,Helper T Cell,Helper-Inducer T-Lymphocytes,Inducer Cell,Inducer Cells,T-Cells, Helper-Inducer,T-Lymphocytes, Helper,T-Lymphocytes, Inducer,Helper T-Cells,Cell, Helper T,Cells, Helper T,Helper Inducer T Lymphocytes,Helper T Cells,Helper T-Cell,Helper T-Lymphocyte,Helper T-Lymphocytes,Helper-Inducer T-Cell,Helper-Inducer T-Cells,Helper-Inducer T-Lymphocyte,Inducer T-Lymphocyte,Inducer T-Lymphocytes,T Cell, Helper,T Cells, Helper,T Cells, Helper Inducer,T Lymphocytes, Helper,T Lymphocytes, Helper Inducer,T Lymphocytes, Inducer,T-Cell, Helper,T-Cell, Helper-Inducer,T-Cells, Helper,T-Lymphocyte, Helper,T-Lymphocyte, Helper-Inducer,T-Lymphocyte, Inducer
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
September 1997, Virus research,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
November 2010, Microbes and infection,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
August 1993, The Journal of general virology,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
January 1995, Microbiology and immunology,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
November 2004, The Journal of general virology,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
March 2018, Journal of virology,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
July 2015, Vaccine,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
November 2021, Viruses,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
August 1989, The Journal of general virology,
B Dietzschold, and M Gore, and D Marchadier, and H S Niu, and H M Bunschoten, and L Otvos, and W H Wunner, and H C Ertl, and A D Osterhaus, and H Koprowski
December 1997, Journal of virology,
Copied contents to your clipboard!